Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Merck & Co Inc DRC (MRK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
28,351.00 +1431.50    +5.32%
25/04 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 22,740
  • Bid/Ask: 28,216.50 / 28,357.00
  • Day's Range: 27,151.00 - 28,351.00
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110277 
Merck & Co DRC 28,351.00 +1431.50 +5.32%

BA:MRK Financials

 
This summary provides an overview of the most significant critical numbers from each of the Merck & Co Inc DRC financial reports, including theMerck & Co Inc DRC income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the BA:MRK financials over time via breakdowns of their annual reports.

Merck & Co., Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 15,775 million compared to USD 14,487 million a year ago. Net income was USD 4,762 million compared to USD 2,821 million a year ago. Diluted earnings per share from continuing operations was USD 1.87 compared to USD 1.11 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRK Income Statement & Profits

Gross margin TTM 73.53%
Operating margin TTM 7.59%
Net Profit margin TTM 0.61%
Return on Investment TTM 4.99%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 14630 15962 15035 14487
Gross Profit 10835 11731 11043 10590
Operating Income 12 5824 -4816 3951
Net Income -1226 4745 -5975 2821

MRK Balance Sheet

Quick Ratio MRQ 0.73
Current Ratio MRQ 1.25
LT Debt to Equity MRQ 89.63%
Total Debt to Equity MRQ 96.51%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 106675 106727 104469 107796
Total Liabilities 69040 65427 65727 60891
Total Equity 37635 41300 38742 46905

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 5.13
Revenue/Share TTM 23.72
Operating Cash Flow  0.96%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 246 7717 3704 1339
Cash From Investing Activities 53 -334 -11443 -2359
Cash From Financing Activities -2245 -4269 3758 -2054
Net Change in Cash -1760 2957 -4074 -2987
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRK Price Commentary

Write your thoughts about Merck & Co Inc DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email